Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Project Baseline

- PMLiVE

Verily and Janssen to collaborate on home-based COVID-19 immune response study

Study will collect information about how COVID-19 affects the immune system

- PMLiVE

Google’s DeepMind AI outperforms doctors on breast cancer screening

System reduced false positive and false negative decisions

- PMLiVE

Novartis and J&J back latest €400m Medicxi biopharma fund

Growing appetite from European investors to back early-stage biotechs

- PMLiVE

Sanofi taps Google’s expertise for digital transformation

Pharma giant embraces AI with new partnership

- PMLiVE

Verily unveils next-gen trials alliance with Novartis, Pfizer

New data methods and tech will be used to streamline trials

- PMLiVE

Google boosts healthcare business with new hire

Tech giant shows ambition in US market

- PMLiVE

Morning brief: Gilead partners with Verily, Roche expands 4DMT partnership and more

A rapid round up of pharma, biotech and healthcare news

Gilead Sciences

Gilead and Verily team up to map inflammatory diseases

Computational analysis could provide deeper understanding of disease

- PMLiVE

Tech-giants allegedly interested in Nokia’s digital health unit

Both Samsung and Google’s Nest could be gearing up for a takeover bid

Google: We’re not a big healthcare company… yet

Alphabet's Eric Schmidt on where his company currently sits within the life sciences landscape

EU flag

Medicxi aims to plug funding gap for European biotech

Fund also backed by Novartis, Alphabet’s Verily unit and the EIF

Google’s Verily backs $300m European life sciences fund

The Medicxi fund for drug development firms also attracts support from Novartis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links